Amyotrophic lateral sclerosis (ALS) is a degenerative disease that affects the brain and spinal cord. ALS causes a loss of voluntary muscle control that worsens over time. This affects movements like talking, swallowing, and walking.
Unfortunately, no cure has been found yet. But treatments are available that can reduce symptoms and may help people with ALS to live longer.
The famous baseball player Lou Gehrig developed symptoms of the condition in the 1930s, and thats why its also known as Lou Gehrigs disease.
ALS can be classified as either sporadic or familial. Most cases are sporadic. That means no specific cause is known.
Familial ALS happens when the condition is inherited from a parent. Only about 5 to 10 percent of ALS cases are familial.
Other causes of ALS arent well understood. Some factors that scientists think might contribute to ALS include:
Military veterans are thought to be at higher risk for ALS, though the reasons for this are unclear. Some research suggests that smoking is a risk factor for ALS. Research on other possible environmental triggers is ongoing.
Every year, about 5,000 people in the United States are diagnosed with ALS. Around 30,000 people in the United States are currently living with the condition. ALS affects people in all racial, social, and economic groups.
A 2016 study suggests that ALS is becoming more common. This may be because the population is aging.
Both sporadic and familial ALS are associated with a progressive loss of motor neurons. As motor neurons become damaged, a person with ALS will start to lose control of movements in their limbs, mouth, or throat.
There are two main types of ALS. Each one is associated with a different set of symptoms at the time of diagnosis.
Around 70 percent of people with ALS have whats known as limb onset ALS. This means that symptoms first appear in the arms or legs.
Symptoms in the arms (upper limb onset) include:
Symptoms in the legs (lower limb onset) include:
Early symptoms are usually in either the arms or the legs, not both. Limb onset ALS usually progresses more slowly than other types.
Bulbar onset ALS is less common. In this type, ALS first affects a part of the brainstem known as the corticobulbar area. Symptoms include:
There are also rare sub-types of ALS that are defined by other symptoms present at the time of diagnosis. These include respiratory onset ALS when problems with the breathing muscles are the earliest sign of illness.
You have two main types of motor neurons in your body: upper motor neurons and lower motor neurons. They work together to allow your brain to communicate with your muscles to make voluntary movements possible.
For example, when you decide to move your finger, your upper motor neurons first send signals from your brain to your spinal cord. Then, lower motor neurons carry signals from the spinal cord to the muscles that move your finger.
By definition, ALS affects both upper and lower motor neurons. But the condition may start by affecting one type more than the other, either the upper or the lower. Each type can result in different symptoms.
Symptoms of upper motor neuron disease include:
Symptoms of lower motor neuron disease include:
Weakness happens with both types of motor neuron disease.
The earliest symptoms of MS may include small muscle twitches in your:
But its normal to notice muscle twitches from time to time. Theyre usually not a cause for concern. In early MS, muscle twitches are likely to become more frequent over time.
Other early signs of ALS may include problems performing everyday tasks. This could mean difficulty climbing stairs or getting up from a chair. Its also possible to have difficulty speaking or swallowing, or weakness in the arms, hands, or legs. You may also notice cramping.
Early symptoms tend to be asymmetrical, which means they only happen on one side.
As the condition progresses, the symptoms generally spread to both sides of the body. Muscle weakness, weight loss, and muscle atrophy are common. In the late stages of ALS, paralysis of the muscles occurs. Paralysis means the complete loss of voluntary movements.
ALS doesnt affect your senses, like seeing or hearing. Bowel and bladder control can be affected in later stages of the disease.
ALS is a terminal illness, which means that it eventually results in loss of life. People typically live with ALS for 2 to 5 years. Some people will live longer. Approximately 20 percent of people live with ALS for over 5 years, and 10 percent for over 10 years. The most common life-ending event in ALS is respiratory failure.
While ALS specifically affects the motor neurons of the brain and spinal cord, other body systems that rely on these neurons will be impacted as the disease progresses. As the ability to control voluntary muscles declines, functions like breathing, speaking, and moving are affected.
ALS progresses differently for everyone. A doctor or neurologist who specializes in the condition can help those with ALS understand what to expect.
ALS can affect many aspects of daily functioning. These include:
ALS causes the muscles controlling breathing to weaken over time. Breathing is likely to become more laborious. As the respiratory system weakens, the risk of pneumonia increases. Eventually, as the condition progresses, a ventilator may be required to assist breathing.
Muscles in the mouth, jaw, and throat tend to lose strength and mobility. Because of this, it can become hard for a person with ALS to make themselves understood when speaking. In severe cases, some people lose the ability to produce speech.
ALS usually affects chewing and swallowing, making eating more difficult. Choking is a possible complication.
Because eating can become challenging and ALS may cause people to burn calories more quickly, its common to experience rapid weight loss and undernutrition.
Standing and walking will generally become more difficult over time. Some people will have trouble moving their arms.
The changes will happen differently for each person. But in general, more muscles will be affected, and the loss of function will become more severe as ALS progresses. Pressure sores are a possible complication as moving becomes harder.
ALS causes cognitive changes in up to 50 percent of cases. These changes can affect language and executive function. Dementia is possible but less common. In ALS, physical changes to the brain can also cause uncontrollable laughing and crying, known as emotional lability.
Some variants of ALS are more commonly associated with cognitive changes, like ALS-frontotemporal spectrum disorder.
Its normal to feel a range of emotions when coping with a serious illness. Managing symptoms and life changes caused by ALS can be emotionally difficult. For some people with ALS, these changes can result in anxiety and depression.
Cognitive changes are common among people with ALS, affecting between 30 and 50 percent of those with the disease. The changes are usually classified as mild to moderate. Problems with reasoning, planning, and slowed thinking are among the most common cognitive symptoms of ALS.
Behavioral changes like emotional lability (uncontrollable laughing and crying) are also possible, even if cognition is otherwise unaffected.
Its less common, but ALS-related dementia can also occur if theres cell degeneration in the frontotemporal regions of the brain.
ALS is usually diagnosed by a neurologist. Theres no specific test for ALS. The process of establishing a diagnosis can take anywhere from weeks to months.
An ALS diagnosis may be considered if someone has nerve and muscle issues that get worse over time. A doctor will watch for increasing problems with symptoms like:
These symptoms can also be caused by a number of other conditions. Therefore, a diagnosis requires your doctor to rule out other health problems. This is done with a series of diagnostic tests, including:
Genetic tests may also be useful for people with a family history of ALS.
Many different areas of functioning can be affected as control over voluntary movements declines. Treatments and supports are available to address most symptoms.
A team of doctors and specialists often work together to treat people with ALS. Specialists involved in the ALS team might include:
Family members should talk with people with ALS about their care. As the condition progresses, some people may need support when making medical decisions.
Connecting with a local ALS society can help people with ALS and their families access resources and support.
Assistive devices like braces, mattresses, and wheelchairs can reduce pain by supporting the body in a more comfortable position.
Some people may need nutritional support, like a feeding tube (enteral feeding).
As speech becomes more difficult, communication tools provide another way to express thoughts and needs. Options include communication boards and electronic assistive communication devices.
If youre considering assistive devices, its best to consult with your healthcare team to find the right options for you.
Two medications riluzole (Rilutek, Tiglutik, Exservan) and edaravone (Radicava) are approved for the treatment of ALS.
Riluzole appears to reduce a particular kind of nerve damage called glutamate-induced excitotoxicity. It can slow the progression of respiratory symptoms and prolong life by several months.
Edaravone (Radicava) appears to help with ALS symptoms by reducing oxidative stress. It can slow the progression of ALS, especially for those in the early stages of the condition.
Other medications may be used to treat the symptoms of ALS. Some of these medications include:
As of 2020, more than 40 potential new medications for ALS are being studied. Clinical trials for stem cell therapy are also underway. But stem cell therapy hasnt yet been proven to be an effective treatment for ALS.
Your doctor may recommend therapies like heat treatments, exercise, and physical therapy to reduce ALS symptoms. These should only be undertaken as directed by your healthcare team.
Massage, meditation, and other complementary and alternative therapies may also help with relaxation and comfort. Before starting any non-medical treatment, its important to discuss it with your doctor.
Theres currently no cure for ALS. But medication and supportive care can improve quality of life. Make it a priority to discuss new or changing symptoms with your healthcare team. Proper treatment and support can help those with ALS live happily and comfortably for as long as possible.
Read more here:
ALS (Lou Gehrig's Disease): Causes, Symptoms & Treatment
- Jake Diekman throws BP session for Rangers | MLB.com - MLB.com - August 6th, 2017 [August 6th, 2017]
- Cerebral palsy: Symptoms, diagnosis, treatment - December 5th, 2017 [December 5th, 2017]
- Hypothalamus - the body's thermostat | ASU - Ask A Biologist - December 6th, 2017 [December 6th, 2017]
- When Stroke Affects the Thalamus - Stroke Connection ... - December 28th, 2017 [December 28th, 2017]
- The Endocrine System: Hypothalamus and Pituitary - December 28th, 2017 [December 28th, 2017]
- Hypothalamus - Anatomy, Blood supply and Function | Kenhub - December 28th, 2017 [December 28th, 2017]
- Ulcerative Colitis - Cedars-Sinai - January 6th, 2018 [January 6th, 2018]
- Ulcerative colitis - Treatment - NHS.UK - January 7th, 2018 [January 7th, 2018]
- Business Directory | Uptown Waterloo Business Improvement Area - January 8th, 2018 [January 8th, 2018]
- Will States Continue To Fund Stem Cell Research? : Shots ... - January 28th, 2018 [January 28th, 2018]
- Spinal Cord Injuries - emedicine.medscape.com - February 15th, 2018 [February 15th, 2018]
- Spinal Cord Injuries - spine.org - February 15th, 2018 [February 15th, 2018]
- Journal of Clinical & Experimental Cardiology - Open Access Journals - April 10th, 2018 [April 10th, 2018]
- Cardiology Treatment - Fortis Healthcare - April 10th, 2018 [April 10th, 2018]
- Biology Junction - April 12th, 2018 [April 12th, 2018]
- Managing Right Ventricular Failure in PAH: An Algorithmic ... - April 14th, 2018 [April 14th, 2018]
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in ... - April 22nd, 2018 [April 22nd, 2018]
- Cardiovascular Pharmacotherapeutics: William H. Frishman ... - May 13th, 2018 [May 13th, 2018]
- 13 Super Foods Good for Eczema - Top Eczema Treatments - May 15th, 2018 [May 15th, 2018]
- Diagnosis & Treatment of Parkinson's - ParkinsonsDisease.net - May 30th, 2018 [May 30th, 2018]
- Arizona Heart Rhythm Center - June 10th, 2018 [June 10th, 2018]
- Ayurvedic Medicines for Ulcerative Colitis | Natural ... - June 21st, 2018 [June 21st, 2018]
- Weinstein Cardiovascular Development and Regeneration Meeting - June 30th, 2018 [June 30th, 2018]
- Ulcerative Colitis Information Centre - July 31st, 2018 [July 31st, 2018]
- Sudden Death in Dogs - Pet Health Network | Pet Health ... - August 7th, 2018 [August 7th, 2018]
- Coronary Heart Disease - Ischaemic heart disease - British ... - August 21st, 2018 [August 21st, 2018]
- Cardiac Rehabilitation: Overview, History and Definition ... - August 25th, 2018 [August 25th, 2018]
- Difference between Cardiac Arrest and Respiratory Arrest ... - August 25th, 2018 [August 25th, 2018]
- ECM for Pericardial Closure - Aziyo - August 25th, 2018 [August 25th, 2018]
- Adult Mental Health | Georgia Department of Behavioral Health ... - September 6th, 2018 [September 6th, 2018]
- Mental Health | ECLKC - September 6th, 2018 [September 6th, 2018]
- Mental Health - The Church of Jesus Christ of Latter-day Saints - September 6th, 2018 [September 6th, 2018]
- Center for Vascular Biology - Home | UConn Health - September 22nd, 2018 [September 22nd, 2018]
- # Diabetes Stem Cell Research Diabetes Care Measures - September 30th, 2018 [September 30th, 2018]
- Cardiac Rhythm Disturbances | The Patient Guide to Heart ... - November 2nd, 2018 [November 2nd, 2018]
- Arrhythmia | Cleveland Clinic - November 2nd, 2018 [November 2nd, 2018]
- Hyperbaric Oxygen Therapy for Wound Healing | Johns ... - November 13th, 2018 [November 13th, 2018]
- NIMH Home - November 24th, 2018 [November 24th, 2018]
- What is an interventional cardiologist? | Heart Surgeries ... - November 26th, 2018 [November 26th, 2018]
- Molecular Cardiology Research Institute Boston | Tufts ... - November 29th, 2018 [November 29th, 2018]
- Lower vascular plant | botany | Britannica.com - December 7th, 2018 [December 7th, 2018]
- Welcome to the ABG Tutorial Welcome to Hansen - December 12th, 2018 [December 12th, 2018]
- Cardiac catheterization - Wikipedia - December 12th, 2018 [December 12th, 2018]
- Stem Cell Research & Therapy | Home page - December 22nd, 2018 [December 22nd, 2018]
- Journal of Stem Cell Research and Therapy- Open Access ... - December 22nd, 2018 [December 22nd, 2018]
- Stem-cell therapy - Wikipedia - December 22nd, 2018 [December 22nd, 2018]
- Cardiology and Interventional Cardiology - December 23rd, 2018 [December 23rd, 2018]
- Rhode Island Interventional Cardiology | Cardiovascular ... - December 23rd, 2018 [December 23rd, 2018]
- Interventional Cardiology Certification Policies | ABIM.org - December 23rd, 2018 [December 23rd, 2018]
- Interventional Cardiology - Boston Scientific - December 23rd, 2018 [December 23rd, 2018]
- 9 Benefits of Human Growth Hormone (Along with Side ... - December 27th, 2018 [December 27th, 2018]
- Growth hormone deficiency - Wikipedia - December 27th, 2018 [December 27th, 2018]
- Dr. Lorrie Kirshenbaum, Cardiac Gene Biology | St ... - January 28th, 2019 [January 28th, 2019]
- Cardiomyopathy - CardioSmart - February 8th, 2019 [February 8th, 2019]
- Centenary Institute | Medical Research, Life Saving Research - February 24th, 2019 [February 24th, 2019]
- Cardiovascular Medicine | Department of Medicine - March 29th, 2019 [March 29th, 2019]
- Rapid Test Market 2019 with Recent Trends, Revenue, Demand and Top Manufactures- Bureau Veritas, SGS SA, Intertek Group plc, Eurofins Scientific -... - October 11th, 2019 [October 11th, 2019]
- Medical Imaging Equipment Market Research Report 2019: Global Industry Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast To... - October 11th, 2019 [October 11th, 2019]
- Analysis on the Global DNA Read, Write & Edit Market, 2017-2019 and Forecast to 2024 - Yahoo Finance - October 11th, 2019 [October 11th, 2019]
- Cardiac Surgery Instruments Market is Expected to Tread a Steady Growth Trajectory by Clocking a CAGR of 5.9% from 2017 to 2022 - Health News Office - October 24th, 2019 [October 24th, 2019]
- PEDIATRIC MEDICAL DEVICES MARKET IS PROJECTED TO EXPAND AT A CAGR OF 8.0% FROM 2018 TO 2026 - Health News Office - November 1st, 2019 [November 1st, 2019]
- myTAIHEART Test Provides Evidence for Injury from Biopsy of Heart Transplant Recipients Cardiology2.0 - Cardiology2.0 - November 1st, 2019 [November 1st, 2019]
- Mental health and your heart - British Heart Foundation - November 19th, 2019 [November 19th, 2019]
- BUZZ-U.S. STOCKS ON THE MOVE-Cango, Gulfport Energy, Abiomed, Standard Diversified, Wanda Sports, Eidos - Nasdaq - November 19th, 2019 [November 19th, 2019]
- Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT - AJMC.com Managed Markets Network - November 19th, 2019 [November 19th, 2019]
- Hundreds walk to defeat ALS in Ancient City - St. Augustine Record - November 22nd, 2019 [November 22nd, 2019]
- Living with Lung Cancer: The Silver Linings - Curetoday.com - November 22nd, 2019 [November 22nd, 2019]
- Building the human spinal cord atlas - SynBioBeta - November 22nd, 2019 [November 22nd, 2019]
- The Week That Wasn't: Keto and the Flu, Human Cyborg, Duvet Disease - Medscape - November 22nd, 2019 [November 22nd, 2019]
- ALS advance offers hope for those diagnosed with deadly disease - WRAL.com - November 22nd, 2019 [November 22nd, 2019]
- ALS Stem Cell Therapy Developer Seeks Amendment to its AstroRx Trial - ALS News Today - November 22nd, 2019 [November 22nd, 2019]
- Former Boston Globe writer, current NHL executive Snow diagnosed with ALS | College Hockey - USCHO - December 23rd, 2019 [December 23rd, 2019]
- AB Science announces the publication of new results in the peer-reviewed journal Glia that further support masitinib's potential mode of action in ALS... - December 23rd, 2019 [December 23rd, 2019]
- Christmas in the City thrills homeless families, takes on poignancy with founders ALS diagnosis - The Boston Globe - December 23rd, 2019 [December 23rd, 2019]
- Amylyx Pharmaceuticals Announces AMX0035 Demonstrated Statistically Significant Treatment Benefit for People with ALS in the CENTAUR Trial - Business... - December 23rd, 2019 [December 23rd, 2019]
- RADICAVA (edaravone) - December 23rd, 2019 [December 23rd, 2019]
- List of Amyotrophic Lateral Sclerosis Medications (5 Compared ... - December 23rd, 2019 [December 23rd, 2019]
- Neuropore Completes Phase 1 Clinical Trial in Healthy Volunteers with NPT520-34, a Therapeutic Candidate Aimed at Treating Parkinson's Disease and... - January 14th, 2020 [January 14th, 2020]
- Comprehensive Analysis on Prostacyclin Market based on types and application - Technology Magazine - January 18th, 2020 [January 18th, 2020]
- N.J. karate legend who inspired thousands loses battle with ALS - NJ.com - January 18th, 2020 [January 18th, 2020]